Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCG administration before frozen-thawed embryo transfer in women with recurrent implantation failure
IRCT20200305046702N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of human chorionic gonadotropin, progesterone and estradiol in infertility and Recurrent Implantation Failure (RIF) (3 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: chemical pregnancy and clinical pregnancy. Started Jun 2020; status: completed.
02
Drugs
human chorionic gonadotropinprogesteroneestradiol
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20200305046702N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200305046702N1.